Adjunctive pregabalin for uncontrolled partial-onset seizures: Findings from a prospective audit

Acta Neurologica Scandinavica

Volumn 124, Issue 2, 2011, Pages 142-145

  Stephen, L J ^a   Parker, P ^a   Kelly, K ^a   Wilson, E A ^a   Leach, V ^a   Brodie, M J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antiepileptic drugs; Epilepsy; Seizures

Indexed keywords

PREGABALIN;

ADD ON THERAPY; ADULT; AGED; ATAXIA; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DIPLOPIA; DISINHIBITION; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; EDEMA; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MYOCLONUS; NOTE; PARESTHESIA; PARTIAL ONSET SEIZURE; PROSPECTIVE STUDY; RASH; SEDATION; SEIZURE; SIDE EFFECT; SLOWED THINKING; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960138602     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01507.x     Document Type: Note

References (15)

1. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004;45:13-8.
2. Lozsadi D, Hemming K, Marson AG. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2009, Art No: CD005612. DOI.
3. Beyenburg S, Stavem K, Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta analysis. Epilepsia 2010;51:7-26.
4. Chadwick DW, Marson T. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. Epilepsia 2007;48:1259-63.
5. Zwarenstein M, Treweek S, Gagnier JJ et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Br Med J 2008;337:1223-6.
6. Stephen LJ, Sills GJ, Brodie MJ. Topiramate in refractory epilepsy: a prospective observational study. Epilepsia 2000;41:977-80.
7. Mohanraj R, Parker PG, Kelly K, Stephen LJ, Brodie MJ. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 2005;14:23-7.
8. Stephen LJ, Kelly K, Wilson EA, Parker P, Brodie MJ. A prospective audit of adjunctive zonisamide in an everyday clinical setting. Epilepsy Behav 2010;17:455-60.
9. Carreno M, Maestro I, Molins A et al. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure 2007;16:709-12.
10. Hoppe C, Rademacher M, Hoffmann JM, Schmidt D, Elger CE. Bodyweight gain under pregabalin therapy in epilepsy: mitigation by counselling patients? Seizure 2008;17:327-32.
11. Brandt C, May TW, Pohlmann-Eden B et al. Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients. Seizure 2009;18:634-8.
12. Yuen AW, Singh R, Bell GS et al. The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre. Epilepsy Res 2009;87:120-3.
13. Valentin A, Moran N, Hadden R et al. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England. Seizure 2009;18:450-2.
14. Gil-Nagel A, Zaccara G, Baldinetti F, Leon T. Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled analysis of four randomised placebo-controlled trials. Seizure 2009;18:184-92.
15. Huppertz H-J, Feuerstein TJ, Schulze-Bonhage A. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia 2001;42:790-2.